Candel Therapeutics (CADL) EPS (Basic) (2020 - 2025)
Candel Therapeutics' (CADL) quarterly EPS (Basic) came in at -$0.55 in Q4 2025, down 41.03% year-on-year from -$0.93 in Q4 2024, and down 161.9% quarter-over-quarter from -$0.21 in Q3 2025.
Candel Therapeutics (CADL) EPS (Basic) (2020 - 2025) Analysis & Trends
Candel Therapeutics has disclosed EPS (Basic) across 6 years of filings, most recently posting -$0.55 for Q4 2025.
- EPS (Basic) for Q4 2025 came in at -$0.55, down 41.03% year-over-year; the trailing twelve-month figure through Dec 2025 was -$0.7 (up 59.77% YoY), and the FY2025 annual result was -$0.72, up 58.62% from the prior year.
- EPS (Basic) came in at -$0.55 for Q4 2025 at Candel Therapeutics, down from -$0.21 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.51 in Q4 2021 to a low of -$1.46 in Q2 2021.
- The 5-year median for EPS (Basic) is -$0.3 (2022), against an average of -$0.32.
- Across the five-year window, EPS (Basic) surged 156.67% in 2021 and slumped 900.0% in 2023, its largest moves.
- Candel Therapeutics' EPS (Basic) stood at $0.51 in 2021, then plunged by 133.33% to -$0.17 in 2022, then plunged by 123.53% to -$0.38 in 2023, then slipped by 2.63% to -$0.39 in 2024, then slumped by 41.03% to -$0.55 in 2025.
- The last three EPS (Basic) figures came in at -$0.55 (Q4 2025), -$0.21 (Q3 2025), and -$0.09 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Candel Therapeutics | 440.62 Mn | 440.62 Mn | - | -0.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.55 |
| Sep 30, 2025 | -0.21 |
| Jun 30, 2025 | -0.09 |
| Mar 31, 2025 | 0.15 |
| Dec 31, 2024 | -0.39 |
| Sep 30, 2024 | -0.33 |
| Jun 30, 2024 | -0.74 |
| Mar 31, 2024 | -0.28 |
| Dec 31, 2023 | -0.38 |
| Sep 30, 2023 | -0.29 |
| Jun 30, 2023 | -0.33 |
| Mar 31, 2023 | -0.30 |
| Dec 31, 2022 | -0.17 |
| Sep 30, 2022 | -0.30 |
| Jun 30, 2022 | -0.14 |
| Mar 31, 2022 | -0.03 |
| Dec 31, 2021 | 0.51 |
| Sep 30, 2021 | -0.69 |
| Jun 30, 2021 | -1.46 |
| Mar 31, 2021 | -0.38 |